Predictive Biomarker for Endoscopic Therapy in Chronic Pancreatitis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Predictive Biomarker for Endoscopic Therapy in Chronic Pancreatitis — Stella

Home/Chronic Pancreatitis/

View on ClinicalTrials.gov

Recruiting

Back to Chronic Pancreatitis trials

Trial locations(1 site)

United States

NYU Langone Health, New York, New York

Key details

Sponsor

NYU Langone Health

Collaborators

National Institute of Neurological Disorders and Stroke (NINDS)

Enrollment target

~100 participants

Started

November 2023

Primary completion

March 2027

Age range

18 Years and older

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.